Keywords
Autism
Cannabis
How to Cite
Copyright © | All rights reserved.
The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.
Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.
Total reproduction
It is expressly prohibited and must be authorized by the journal.
Abstract
Objective: Analyze the improvement of patients with Autism Spectrum Disorder (ASD) with Cannabis-based treatment. Methods: An integrative review was carried out in which the following databases were used: Biblioteca Virtual em Saúde (BVS), National Library of Medicine and National Institutes of Health (Pubmed), Web of Science, Cochrane, Scientific Electronic Library Online (Scielo), National Library of Medicine's (NLM) and EBSCO, selecting 22 articles in the end. Furthermore, the boolean operators “AND”, “OR” were used in research related to ASD and Cannabis. The inclusion criteria used were: articles published in the last 5 years, written in Portuguese, English and Spanish, published in scientific journals. Results: Cannabis-based treatment showed satisfactory results in the treatment of patients with ASD in the studies analyzed. Showing improvement in the main symptoms of the disorder, such as: sleep disturbances, difficulty in social interaction, dietary restrictions, behavioral crises and seizures. Final considerations: Analyzing the articles, it was possible to see that the use of Cannabis as a form of treatment in patients with ASD brought positive results. However, more studies with a longer follow-up period are needed to prove that the use of Cannabis is beneficial.
References
ACOSTA LE e LAVAGNINO NJ. Construcción de una terapia de cannabis, autocultivo y autoatención como camino para mejorar la calidad de vida: estudio de un caso-ejemplo en Argentina. Revista Eletrônica Scripta Ethnologica, 2022; 44: 1-31.
AGARWAL R, et al. Current state of evidence of cannabis utilization for treatment of autism spectrum disorders. Revista eletrônica BMC Psychiatry, 2019; 19(1): 328.
ARAN A, et al. Cannabinoid treatment for autism:a proof-of-concept randomized trial. Revista eletrônica Molecular Autism, 2021; 12: 6.
BAR-LEV SCHLEIDER L, et al. Real life Experience of Medical Cannabis Treatment in Autism: Analysis of Safety and Efficacy. Revista eletrônica Scientific Reports, 2019; 9: 200.
BRASIL. Manual do Ministério da Saúde. 2022. Disponível em: https ://www.gov.br/saude/pt-br/assuntos/noticias/2022/abril/tea-saiba-o-que-e-o-transtorno-do-espec tro-autista-e-como-o-sus-tem-dado-assistencia-a-pacientes-e-familiares. Acessado em: 05 jun. 2024.
CRISTINO L, et al. Cannabinoids and the expanded endocannabinoid system in neurological disorders. Revista eletrônica Nature Reviews Neurology, 2019; 16: 9–29.
CRUMP C, et al. Preterm or Early Term Birth and Risk of Autism. Revista eletrônica American Academy of Pediatrics, 2021.
DUVALL SW, et al. Ethical Implications for Providers Regarding Cannabis Use in Children With Autism Spectrum Disorders. Revista eletrônica American Academy of Pediatrics, 2019; 143(2).
FLEURY-TEIXEIRA P, et al. Effects of CBD-Enriched Cannabis sativa Extract on Autism Spectrum Disorder Symptoms: An Observational Study of 18 Participants Undergoing Compassionate Use. Revista eletrônica Frontiers in Neurology, 2019; 10: 1145.
MAENNER MJ, et al. Prevalence and Characteristics of Autism Spectrum Disorder Among Children Aged 8 Years — Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2020. Revista eletrônica MMWR Surveill Summ. 2024; 72(2): 1-14.
MALES WITH AUTISM SPECTRUM DISORDER. Journal of Autism and Developmental Disorders; 2022; 52: 4164–4171.
MANSELL H, et al. Medical cannabis in school[s: A qualitative study on the experiences of clinicians. Revista eletrônica Paediatrics & Child Health, 2022; 28: 113-118.
MANSELL H, et al. Medical cannabis in schools: The experiences of caregivers. Revista eletrônica Paediatrics & Child Health, 2023; 28: 102–106.
NETO P, et al. Cannabis: 12.000 anos de experiências e preconceitos. BrJP. São Paulo. 2023; 6(2): 80-4.
OMS. Transtorno do espectro autista. Disponível em: https ://www.paho.org/pt/topicos/transtorno-do-espectro-autista. Acesso em: 8 de junho de 2024.
PONTON JA, et al. A pediatric patient with autism spectrum disorder and epilepsy using cannabinoid extracts as complementary therapy: a case report. Revista eletrônica Journal of Medical Case Reports, 2020; 14: 162.
QUILLET JC, et al. A machine learning approach for understanding the metabolomics response of children with autism spectrum disorder to medical cannabis treatment. Revista eletrônica Scientifc Reports, 2023; 13: 13022.
RANG HP, DALE MM, RITTER JM, FLOWER RJ, HENDERSON G. Farmacologia. Rio de Janeiro, 9.
RAZ N, et al. Terpene-Enriched CBD oil for treating autism-derived symptoms unresponsive to pure CBD: Case report. Revista eletrônica Frontiers in Pharmacology, 2022; 13: 979403.
SCHNAPP A, et al. A Placebo-Controlled Trial of Cannabinoid Treatment for Disruptive Behavior in Children and Adolescents with Autism Spectrum Disorder: Effects on Sleep Parameters as Measured by the CSHQ. Revista eletrônica Biomedicines, 2022; 13; 10(7): 1685.
SIANI-ROSE M, et al. Cannabis-Responsive Biomarkers: A Pharmacometabolomics-Based Application to Evaluate the Impact of Medical Cannabis Treatment on Children with Autism Spectrum Disorder. Revista eletrônica Cannabis and Cannabinoid Research, 2021; 8(1): 126-137.
SILVA EAD Junior, et al. Evaluation of the efficacy and safety of cannabidiol-rich cannabis extract in children with autism spectrum disorder: randomized, double-blind and controlled placebo clinical trial. Revista eletrônica Trends in Psychiatry and Psychotherapy, 2024; 46: 20210396 – 3.
SOLEITI MA, et al. Brief Report: Suspected Cannabis‐Induced Mania and Psychosis in Young Adult
STOLAR O, et al. Medical cannabis for the treatment of comorbid symptoms in children with autism spectrum disorder: An interim analysis of biochemical safety. Revista eletrônica Frontiers in Pharmacology, 2022; 29(13): 977484.
ZAMBERLETTI E, et al. The Endocannabinoid System and Autism Spectrum Disorders: Insights from Animal Models. International Journal of Molecular Sciences, 2017; 18(9): 1916.
ZOU S e KUMAR U. Cannabinoid Receptors and the Endocannabinoid System: Signaling and Function in the Central Nervous System. Revista eletrônica International Journal of Molecular Sciences, 2018; 19(3): 833.